Cargando…
Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
Heparin-induced thrombocytopenia is a life-threatening immune-mediated complication of unfractionated heparin therapy. Fondaparinux is a therapeutic alternative, but it has limited evidence for its use in patients on extracorporeal membrane oxygenation (ECMO). We present a series of three adult pati...
Autores principales: | Rychlíčková, Jitka, Šrámek, Vladimír, Suk, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996216/ https://www.ncbi.nlm.nih.gov/pubmed/36910487 http://dx.doi.org/10.3389/fmed.2023.1112770 |
Ejemplares similares
-
The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018) -
Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020) -
Heparin-free veno-venous extracorporeal membrane oxygenation in non-trauma patients with difficult airways for surgery
por: Chen, Hongya, et al.
Publicado: (2023) -
Fundamentals of weaning veno-arterial and veno-venous extracorporeal membrane oxygenation
por: Tsiouris, Athanasios, et al.
Publicado: (2023) -
Heparin-free veno-venous extracorporeal membrane oxygenation in a multiple trauma patient: A case report
por: Lee, Youn Young, et al.
Publicado: (2020)